|
TSUJIKAWA Kazutake
|
Organization 【 display / non-display 】
-
1998.04.01 - 2006.03.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Research Assistant
-
2006.04.01 - 2007.03.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Associate Professor
-
2007.04.01 - 2010.08.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Associate Professor
-
2010.09.01 - 2012.03.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Professor
-
2012.04.01 - 2017.06.30, Medical Pharmacy, Graduate School of Pharmaceutical Sciences, Professor
-
2017.07.01 - , Graduate School of Pharmaceutical Sciences, Professor
-
2012.04.01 - , Drug Innovation Center, Graduate School of Pharmaceutical Sciences
Education 【 display / non-display 】
Osaka University of Pharmaceutical Sciences Faculty of Pharmaceutical Science Graduated | 1982.03 | |
Osaka University Graduate School, Division of Pharmaceutical Sciences Completed | 1984.03 | |
Osaka University Graduate School, Division of Pharmaceutical Sciences Completed | Doctor (Pharmacology) | 1987.12 |
Employment Record 【 display / non-display 】
Osaka University, Grad. Sch. Pharm. Sci., Associate Professor | 2006.04 - |
Grad. Sch. Pharm. Sci., Osaka University, Professor | 2010.09 - |
Research topics 【 display / non-display 】
-
Molecular-targeted therapeutic medicine of carcinomas
Functional analysis of AlkB homolog family molecules
RNA epigenetics
Regulation of immune and inflammatory systems with neuropeptides
Pharmaceutical hygiene and biochemistry-related, Clinical pharmacy-related, Immunology-related
Academic Papers 【 display / non-display 】
-
The CalcR-PKA-Yap1 axis is critical for maintaining quiescence in muscle stem cells. , Zhang L., Noguchi, Y., Nakayama, H., Kaji, T., Tsujikawa, K., Ikemoto-Uezumi, M., Uezumi, A., Okada, Y., Doi, T., Watanabe, S., Braun, T., Fujio, Y., Fukada, SI. , Cell Rep. ,29(8) 2154-2163, 2019.11, Papers
-
Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential., Inaba S, Hinohara A, Tachibana M, Tsujikawa K, Fukada SI, PloS one,13(10) e0205467, 2018.04, Other
-
Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells In Vivo., Ueda M, Shimizu T, Mabuchi M, Horiike K, Kitae K, Hase H, Ueda Y, Tsujikawa K, Tanaka A., Anticancer Res. ,38(1):211-218., 2018.01, Papers
-
2. RAMP1 signaling improves lymphedema and promotes lymphangiogenesis in mice., Mishima T, Ito Y, Nishizawa N, Amano H, Tsujikawa K, Miyaji K, Watanabe M, Majima M., J Surg Res. ,219:50-60, 2017.11, Papers
-
Extracellular vesicles isolated from human renal cell carcinoma tissues disrupt vascular endothelial cell morphology via azurocidin., Jingushi K, Uemura M, Ohnishi N, Nakata W, Fujita K, Naito T, Fujii R, Saichi N, Nonomura N, Tsujikawa K, Ueda K, International journal of cancer, 2017.10, Papers
Books 【 display / non-display 】
-
Special, Regulation of TLR signaling in dendritic cells by neuropeptides, Nagisa Hashimoto, Morihisa Mikami, Kazutake Tsujikawa, 2010.05
-
Special, Protocol of Antibody Experimetn for Protein Research, Kazutake Tsujikawa, Hiroshi Yamamoto, Yodosha, 2004.03
-
Other, Involvement of metallothionein in the prevention of gastric mucosal lesions in 'Metallothionein in biology and medicine', 1991
Awards 【 display / non-display 】
-
BioBusiness Award, Kazutake Tsujikawea, 2011.03